Compare ALEMBIC PHARMA with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ELDER PHARMA ALEMBIC PHARMA/
ELDER PHARMA
 
P/E (TTM) x 15.8 -0.2 - View Chart
P/BV x 6.3 0.1 6,210.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   ELDER PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
ELDER PHARMA
Jun-14
ALEMBIC PHARMA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs664380 174.7%   
Low Rs412188 219.4%   
Sales per share (Unadj.) Rs208.7491.2 42.5%  
Earnings per share (Unadj.) Rs31.0-3.2 -974.3%  
Cash flow per share (Unadj.) Rs37.114.4 257.6%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.2376.5 38.3%  
Shares outstanding (eoy) m188.5220.54 917.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.60.6 446.0%   
Avg P/E ratio x17.4-89.3 -19.5%  
P/CF ratio (eoy) x14.519.7 73.6%  
Price / Book Value ratio x3.70.8 494.7%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4615,833 1,739.3%   
No. of employees `000NANA-   
Total wages/salary Rs m7,4672,179 342.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m39,34710,089 390.0%  
Other income Rs m94257 36.6%   
Total revenues Rs m39,44110,346 381.2%   
Gross profit Rs m8,736-792 -1,103.1%  
Depreciation Rs m1,152361 318.9%   
Interest Rs m1842,756 6.7%   
Profit before tax Rs m7,493-3,653 -205.1%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m1,568125 1,252.5%   
Profit after tax Rs m5,844-65 -8,942.2%  
Gross profit margin %22.2-7.8 -282.9%  
Effective tax rate %20.9-3.4 -610.6%   
Net profit margin %14.9-0.6 -2,292.9%  
BALANCE SHEET DATA
Current assets Rs m19,5779,240 211.9%   
Current liabilities Rs m14,8969,998 149.0%   
Net working cap to sales %11.9-7.5 -158.4%  
Current ratio x1.30.9 142.2%  
Inventory Days Days9046 193.8%  
Debtors Days Days4560 75.7%  
Net fixed assets Rs m27,09710,124 267.7%   
Share capital Rs m377206 183.3%   
"Free" reserves Rs m26,8115,582 480.3%   
Net worth Rs m27,1887,734 351.6%   
Long term debt Rs m4,9934,889 102.1%   
Total assets Rs m47,77822,882 208.8%  
Interest coverage x41.7-0.3 -12,819.8%   
Debt to equity ratio x0.20.6 29.0%  
Sales to assets ratio x0.80.4 186.8%   
Return on assets %12.611.8 107.3%  
Return on equity %21.5-0.8 -2,543.5%  
Return on capital %23.622.3 105.8%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m19,453307 6,344.7%   
Fx outflow Rs m6,065125 4,840.2%   
Net fx Rs m13,388181 7,384.4%   
CASH FLOW
From Operations Rs m8,12011,754 69.1%  
From Investments Rs m-7,556-561 1,348.1%  
From Financial Activity Rs m590-6,762 -8.7%  
Net Cashflow Rs m1,1534,432 26.0%  

Share Holding

Indian Promoters % 74.1 39.6 187.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 7.5 38.7%  
FIIs % 9.1 16.8 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 36.1 38.5%  
Shareholders   49,328 16,479 299.3%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  UNICHEM LAB  ORCHID PHARMA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Trades 279 Points Lower; Indicates Gap-Down Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a negative note today. At 8:10 am, it was trading down by 279 points, or 1.9% lower at 14,900 levels.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 26, 2021 09:40 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS